Prediction of doxorubicin resistance in gastrointestinal cancer by P-glycoprotein stainingMasaji Yamauchi, Hiroshi Takagi, Heiji Kumazawa et al.|European Journal of Cancer|1992Cited by 16
Establishment of Drug Resistance in Human Gastric and Colon Carcinoma Xenograft LinesTetsuya Satta, Hiroshi Takagi, Katsuki Itou et al.|Japanese Journal of Cancer Research|1991Cited by 13
Polyoxyethylene‐modified Superoxide Dismutase Reduces Side Effects of Adriamycin and Mitomycin CShingo Kawasaki, Hiroshi Takagi, Seiji Akiyama et al.|Japanese Journal of Cancer Research|1992Cited by 11
Statistical and Pathological Study of Carcinoma in the Gastric Remnant. Risk of Development of Carcinoma in the Gastric Remnant after Gastrojejunostomy.Ken Kondo, Hiroshi Takagi, Masaji Yamauchi et al.|日本消化器外科学会雑誌|1991Cited by 8
A newly developed drug delivery system using fine particles of activated charcoal for targeting chemotherapy.K Ito, Hiroaki Takagi, K Kiriyama et al.|PubMed|1991Cited by 5